Globenewswire
Search documents
Geron Plans to Present at Upcoming Investor Conferences
Globenewswire· 2026-02-23 13:00
FOSTER CITY, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that members of the management team are scheduled to present at the following investor conferences: TD Cowen 46th Annual Healthcare ConferenceFireside Chat on Monday, March 2 at 1:10 p.m. ET in Boston, MABarclays 28th Annual Global Healthcare ConferenceFireside Chat on Tuesday, March 10 at 10:30 a. ...
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
Globenewswire· 2026-02-23 13:00
ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to enzyme replacement therapy MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (OTC: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases, today announced that it has entered into an exclusive worldwide license agreement with Duke University fo ...
Alignment Healthcare to Present at the Leerink Partners Global Healthcare Conference
Globenewswire· 2026-02-23 13:00
ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday, March 10, at 3:40 p.m. EST. A webcast and replay of the presentation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their ...
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
Globenewswire· 2026-02-23 13:00
BLFC Sensory Room Image of future sensory Collegium Pharmaceutical Sensory Room for BLFC home matches Scoreboard for BLFC Scoreboard at BLFC Matches at White Stadium with Collegium Branding BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Boston Legacy FC today announced a multi-year partnership with Collegium Pharmaceutical, an emerging biopharmaceutical leader in the Boston area, naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are w ...
B2Gold Announces Leadership Transition
Globenewswire· 2026-02-23 13:00
VANCOUVER, British Columbia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) today announced that as part of the Company’s leadership succession planning, Mr. Clive Johnson has decided to retire from his role as President, Chief Executive Officer (“CEO”) and Director of the Company at the Annual General Meeting of the Company scheduled to be held on June 4, 2026. The Board of Directors has named Mike Cinnamond, Senior Vice President, Financ ...
Mount Logan Capital Inc. Announces $10 Million Share Repurchase Program
Globenewswire· 2026-02-23 13:00
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) today announced that its Board of Directors has authorized a share repurchase program of up to $10 million of the Company’s outstanding common stock through December 31, 2027. The authorization reflects the Company’s continued focus on disciplined capital allocation. It follows the February 2026 completion of its $15 million tender offer, which reduced the Company’s common stock issued and ou ...
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
Globenewswire· 2026-02-23 13:00
KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated biotechnology research and healthcare platform specializing in predictive, preventive, and precision medicine, today announced a peer-reviewed case study in the February 2026 edition of SAGE Open Medical Case Reports. The publication reports findings from nine patients who received autologous Natural Killer (NK) cell infus ...
MKS Inc. to Participate in Morgan Stanley’s Technology, Media & Telecom Conference
Globenewswire· 2026-02-23 13:00
ANDOVER, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that John T.C. Lee, President and Chief Executive Officer, will participate in a fireside chat at Morgan Stanley’s Technology, Media & Telecom Conference on Monday, March 2, 2026 at 3:20 p.m. EST.A live webcast of the session will be available in the Investor Relations section of the company's website at https://investor.mksinst.com/events-and-presen ...
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
Globenewswire· 2026-02-23 13:00
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced positive data from two presentations at the Conference on Retroviruses and Opportunistic Infections (CROI), being held February 22 – 25, 2026 in Denver, Colorado. The pevifoscorvir sodium presentation highlights the Phase 1 monotherapy study of pev ...
Getty Images and Shutterstock Receive Unconditional Antitrust Clearance from U.S. Department of Justice for Proposed Merger
Globenewswire· 2026-02-23 13:00
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (NYSE: GETY) (“Getty Images”) and Shutterstock, Inc. (NYSE: SSTK) announced today that the United States Department of Justice (DOJ) has concluded its review of the companies’ proposed merger of equals and the applicable waiting period under the Hart-Scott-Rodino Act has expired, without conditions. “We are very pleased with the DOJ’s decision in recognizing the merits of this transaction,” said Craig Peters, CEO, Getty Images. “With to ...